Pharma Journalist - Page 4 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Lilly Acquires 4E Therapeutics to Advance Pain Treatments

Altaris to Acquire Simulations Plus in Cash Deal

UK, US Regulators Launch New Collaboration Programme

Cystic Fibrosis Foundation Backs SpliSense With $13 Million

AviadoBio Expands vMiX Gene Therapy Rights Globally

Johnson & Johnson Invests $1 Billion in Vision Expansion

Alixorexton Earns Orphan Drug Status in US, Europe

Chiesi Completes KalVista Acquisition, Expands Rare Disease Portfolio

IMAAVY Shows Strong Results in Rare Blood Disorder Trial

GSK’s Momelotinib Gains Orphan Status for VEXAS Syndrome